Smith & Nephew
SNN
#1503
Rank
NZ$24.07 B
Marketcap
NZ$56.73
Share price
0.81%
Change (1 day)
30.50%
Change (1 year)
Categories
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company.

P/E ratio for Smith & Nephew (SNN)

P/E ratio as of December 2025 (TTM): 29.0

According to Smith & Nephew 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 29.0018. At the end of 2013 the company had a P/E ratio of 18.1.

P/E ratio history for Smith & Nephew from 2001 to 2014

PE ratio at the end of each year

Year P/E ratio Change
201318.172.9%
201210.4-4.92%
201111.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
20.1-30.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
45.7 57.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
36.4 25.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
50.0 72.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Orthofix Medical
OFIX
-5.11-117.60%๐Ÿ‡บ๐Ÿ‡ธ USA
CONMED
CNMD
19.3-33.38%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.